论文部分内容阅读
1目前疗法概况丙型肝炎病毒(HCV)是引发各种肝病的主要原因之一。据世界卫生组织统计,全球现共约有1.7亿慢性HCV感染患者(占全球总人口的近3%),每年新感染者数量达300万~400万人。美国疾病控制与预防中心估计,美国目前有300多万慢性HCV感染患者,年感染人数为3万人。目前慢性HCV
1 Current Therapeutic Profile Hepatitis C virus (HCV) is one of the leading causes of various liver diseases. According to the statistics of the World Health Organization, there are about 170 million people with chronic HCV infection (nearly 3% of the global total) nowadays globally, with 3 million to 4 million newly infected people each year. The Centers for Disease Control and Prevention estimates that there are currently more than 3 million chronic HCV infections in the United States and the number of annual infections is 30,000. The current chronic HCV